Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data

被引:46
|
作者
Wei, Yinghui [1 ,2 ]
Royston, Patrick [1 ]
Tierney, Jayne F. [1 ]
Parmar, Mahesh K. B. [1 ]
机构
[1] Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, London, England
[2] Univ Plymouth, Sch Comp & Math, Ctr Math Sci, Plymouth PL4 8AA, Devon, England
基金
英国医学研究理事会;
关键词
meta-analysis; time-to-event outcomes; non-proportional hazards; restricted mean survival time; CELL LUNG-CANCER; VINORELBINE PLUS CISPLATIN; RESECTED STAGE-I; ADJUVANT CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PROPORTIONAL-HAZARDS; RADICAL CYSTECTOMY; PATIENT DATA; BLADDER; CARCINOMA;
D O I
10.1002/sim.6556
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Meta-analysis of time-to-event outcomes using the hazard ratio as a treatment effect measure has an underlying assumption that hazards are proportional. The between-arm difference in the restricted mean survival time is a measure that avoids this assumption and allows the treatment effect to vary with time. We describe and evaluate meta-analysis based on the restricted mean survival time for dealing with non-proportional hazards and present a diagnostic method for the overall proportional hazards assumption. The methods are illustrated with the application to two individual participant meta-analyses in cancer. The examples were chosen because they differ in disease severity and the patterns of follow-up, in order to understand the potential impacts on the hazards and the overall effect estimates. We further investigate the estimation methods for restricted mean survival time by a simulation study. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:2881 / 2898
页数:18
相关论文
共 50 条
  • [1] Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis
    Charu, Vivek
    Tian, Lu
    Tamura, Manjula Kurella
    Montez-Rath, Maria E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (02): : 260 - 262
  • [2] Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
    Royston, Patrick
    Parmar, Mahesh K. B.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
  • [3] Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
    Patrick Royston
    Mahesh KB Parmar
    [J]. BMC Medical Research Methodology, 13
  • [4] Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example
    de Jong, Valentijn M. T.
    Moons, Karel G. M.
    Riley, Richard D.
    Tudur Smith, Catrin
    Marson, Anthony G.
    Eijkemans, Marinus J. C.
    Debray, Thomas P. A.
    [J]. RESEARCH SYNTHESIS METHODS, 2020, 11 (02) : 148 - 168
  • [5] Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
    A'Hern, Roger P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3474 - +
  • [6] Using median survival in meta-analysis of experimental time-to-event data
    Hirst, Theodore C.
    Sena, Emily S.
    Macleod, Malcolm R.
    [J]. SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [7] Aggregate data meta-analysis with time-to-event outcomes
    Williamson, PR
    Smith, CT
    Hutton, JL
    Marson, AG
    [J]. STATISTICS IN MEDICINE, 2002, 21 (22) : 3337 - 3351
  • [8] Using median survival in meta-analysis of experimental time-to-event data
    Theodore C. Hirst
    Emily S. Sena
    Malcolm R. Macleod
    [J]. Systematic Reviews, 10
  • [9] A COMPARISON OF METHODS FOR META-ANALYSIS OF TIME-TO-EVENT INDIVIDUAL DATA: APPLICATION TO NON HODGKING LYMPHOMA SURVIVAL STUDIES
    Carreras, G.
    Pizzo, A. M.
    [J]. EPIDEMIOLOGIA & PREVENZIONE, 2010, 34 (5-6): : 154 - 154
  • [10] Lymphadenectomy extent and survival of patients with gastric carcinoma: A systematic review and meta-analysis of time-to-event data from randomized trials
    Mocellin, Simone
    Nitti, Donato
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (05) : 448 - 454